Sequence Similarity Clusters for the Entities in PDB 1FVV

Entity #1 | Chains: A,C
CYCLIN-DEPENDENT KINASE 2 protein, length: 298 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 348 369 42
95 % 372 393 34 Flexibility: Low
Max RMSD: 7.4, Avg RMSD: 2.2
PDBFlex
90 % 372 393 40
70 % 372 393 51
50 % 404 448 72
40 % 423 483 64
30 % 3899 4566 2
Entity #2 | Chains: B,D
CYCLIN A protein, length: 260 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 70 84 190
95 % 96 110 188 Flexibility: No
Max RMSD: 1.4, Avg RMSD: 0.4
PDBFlex
90 % 100 114 170
70 % 100 114 188
50 % 100 114 232
40 % 100 114 259
30 % 107 123 262

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 2CCH 2 B, D CYCLIN A2 CYCLIN FOLD FRAGMENT RESIDUES 175-432 9606
2 4EOJ 2 B, D Cyclin-A2 C-terminal fragment 9606
3 6ATH 2 B Cyclin-A2 UNP residues 173-432 9606
4 3DDQ 2 B, D Cyclin-A2 UNP residues 169-430 9913
5 3QHW 2 B, D Cyclin-A2 UNP Residues 163-422 10090
6 4CFV 2 B, D CYCLIN-A2 CDK-ACTIVATING FRAGMENT, RESIDUES 175-432 9606
7 3BHT 2 B, D Cyclin-A2 UNP residues 169-430 9913
8 3TNW 2 B, D Cyclin-A2 cyclin boxes, UNP resdiues 169-430 9913
9 6GU2 2 B G2/mitotic-specific cyclin-B1 9606
10 6GUC 2 B, D Cyclin-A2 9913
11 6GUE 2 B, D Cyclin-A2 9913
12 2C5N 2 B, D CYCLIN A2 9606
13 4BCO 2 B, D CYCLIN-A2 9913
14 3MY5 2 B, D Cyclin-A2 UNP residues 169-430 9913
15 3BHV 2 B, D Cyclin-A2 UNP residues 169-430 9913
16 4BCK 2 B, D CYCLIN-A2 RESIDUES 171-432 9606
17 4BCN 2 B CYCLIN-A2 RESIDUES 171-432 9606
18 4BCN 3 D CYCLIN-A2 RESIDUES 171-431 9606
19 4I3Z 2 B, D Cyclin-A2 UNP RESIDUES 105-421 10090
20 2UUE 2 B, D CYCLIN A2 RESIDUES 174-432 9606
21 2IW9 2 B, D CYCLIN-A2 MONOTHIOGLYCEROL ADDUCT ON RESIDUE 193 A3, RESIDUES 174-432 9606
22 4EOP 2 B, D Cyclin-A2 C-terminal fragment 9606
23 4EOI 2 B, D Cyclin-A2 C-terminal fragment 9606
24 5LQF 2 B, E G2/mitotic-specific cyclin-B1 9606
25 1OIU 2 B, D CYCLIN A2 RESIDUES 174-432 9606
26 1VIN 1 A CYCLIN A HIS 6 TAGGED AT C-TERMINUS 9913
27 3QHR 2 B, D Cyclin-A2 UNP Residues 163-422 10090
28 2C5O 2 B, D CYCLIN A2 9606
29 5CYI 2 B, D Cyclin-A2 UNP residues 174-432 9606
30 4CFU 2 B CYCLIN-A2 CDK-ACTIVATING FRAGMENT, RESIDUES 172-432 9606
31 4CFU 3 D CYCLIN-A2 CDK-ACTIVATING FRAGMENT, RESIDUES 172-432 9606
32 4EOM 2 B, D Cyclin-A2 C-terminal fragment 9606
33 1H1R 2 B, D CYCLIN A2 9606
34 4II5 2 B, D Cyclin-A2 UNP RESIDUES 165-422 10090
35 4EOQ 2 B, D Cyclin-A2 C-terminal fragment 9606
36 1H1S 2 B, D CYCLIN A2 9606
37 4EOO 2 B, D Cyclin-A2 C-terminal fragment 9606
38 4BCP 2 B, D CYCLIN-A2 RESIDUES 171-432 9606
39 4CFN 2 B, D CYCLIN-A2 CDK-ACTIVATING FRAGMENT, RESIDUES 175-432 9606
40 1H1P 2 B, D CYCLIN A2 9606
41 5HQ0 2 B G2/mitotic-specific cyclin-B1 9606
42 4Y72 2 B G2/mitotic-specific cyclin-B1 9606
43 2WEV 2 B, D CYCLIN-A2 CAP-TETRAPEPTIDE INHIBITOR RESIDUES 173-432 9606
44 1OI9 2 B, D CYCLIN A2 RESIDUES 174-432 9606
45 1JSU 2 B CYCLIN A RESIDUES 173 - 432 9606
46 3BHU 2 B, D Cyclin-A2 UNP residues 169-430 9913
47 1QMZ 2 B, D G2/MITOTIC-SPECIFIC CYCLIN A RESIDUES 174-432 9606
48 4EOR 2 B, D Cyclin-A2 C-terminal fragment 9606
49 1P5E 2 B, D Cyclin A2 residues 175-432 9606
50 2CJM 2 B, D CYCLIN A2 RESIDUES 175-432 9606
51 1H26 2 B, D CYCLIN A2 CYCLIN FOLD, RESIDUES 175-432 9606
52 1FIN 2 B, D CYCLIN A RESIDUES 173 - 432 9606
53 1H27 2 B, D CYCLIN A2 CYCLIN FOLD, RESIDUES 175-432 9606
54 1OKW 2 B, D CYCLIN A2 CYCLIN GROOVE-BOUND PEPTIDE ACE-ARG-ARG-LEU-ASN-FCL-NH2 RESIDUES 173-432 9606
55 2IW8 2 B, D CYCLIN-A2 MONOTHIOGLYCEROL ADDUCT ON RESIDUE 193 A3, RESIDUES 174-432 9606
56 4CFW 2 B, D CYCLIN-A2 CDK-ACTIVATING FRAGMENT, RESIDUES 175-432 9606
57 2UZE 2 B, D CYCLIN A2 RESIDUES 175-432 9606
58 1PKD 2 B, D Cyclin A2 9606
59 1OKV 2 B, D CYCLIN A2 RESIDUES 173 - 432 9606
60 2UZL 2 B, D CYCLIN A2 RESIDUES 175-432 9606
61 2V22 2 B, D CYCLIN-A2 CAP-TETRAPEPTIDE INHIBITOR 9606
62 4BCM 2 B CYCLIN-A2 RESIDUES 171-432 9606
63 4BCM 3 D CYCLIN-A2 RESIDUES 171-432 9606
64 1URC 2 B, D CYCLIN A2 RESIDUES 173 - 432 9606
65 1VYW 2 B, D CYCLIN A2 C-TERMINAL PORTION, RESIDUES 174-432 9606
66 2IW6 2 B, D CYCLIN-A2 MONOTHIOGLYCEROL ADDUCT ON RESIDUE 193 A3, RESIDUES 174-432 9606
67 5LMK 2 B, D Cyclin-A2 9606
68 2WFY 2 B, D CYCLIN-A2 RESIDUES 173-432 9606
69 4BCQ 2 B CYCLIN-A2 RESIDUES 169-429 9913
70 4BCQ 3 D CYCLIN-A2 RESIDUES 169-429 9913
71 6GUB 2 B, D Cyclin-A2 9913
72 4EOL 2 B, D Cyclin-A2 C-terminal fragment 9606
73 4EON 2 B, D Cyclin-A2 C-terminal fragment 9606
74 5IF1 2 B, D Cyclin-A2 9606
75 1OL2 2 B, D CYCLIN A2 RESIDUES 173 - 432 9606
76 1H24 2 B, D CYCLIN A2 CYCLIN FOLD FRAGMENT, RESIDUES 175-432 9606
77 2BPM 2 B, D CYCLIN A2 RESIDUES 174-432 (C-TERMINAL PORTION) 9606
78 2WIH 2 B, D CYCLIN-A2 C-TERMINAL PORTION, RESIDUES 173-432 9606
79 1JST 2 B, D CYCLIN A RESIDUES 173-432 9606
80 1OGU 2 B, D CYCLIN A2 RESIDUES 174-432 9606
81 2C6T 2 B, D CYCLIN A2 RESIDUES 175-432 9606
82 2G9X 2 B, D Cyclin-A2 9913
83 6GU3 2 B G2/mitotic-specific cyclin-B1 9606
84 2WPA 2 B, D CYCLIN A2 C-TERMINAL PORTION, RESIDUES 173-432 9606
85 1E9H 2 B, D CYCLIN A3 TRUNCATED FRAGMENT OF CYCLIN A. IN COMPLEX WITH CDK2 CHAINS B AND D ARE ASYMETRIC UNIT COPIES 9606
86 2WXV 2 B, D CYCLIN-A2 C-TERMINAL PORTION, RESIDUES 173-432 9606
87 1OIY 2 B, D CYCLIN A2 RESIDUES 174-432 9606
88 6GUF 2 B, D Cyclin-A2 9913
89 4FX3 2 B, D Cyclin-A2 UNP RESIDUES 175-432 9606
90 3DOG 2 B, D Cyclin-A2 UNP residues 169-430 9913
91 2C5V 2 B, D CYCLIN A2 9606
92 6GU4 2 B G2/mitotic-specific cyclin-B1 9606
93 2UZB 2 B, D CYCLIN-A2 RESIDUES 175-432 9606
94 4EOK 2 B, D Cyclin-A2 C-terminal fragment 9606
95 2I40 2 B, D Cyclin-A2 residues 173-432 9606
96 2X1N 2 B, D CYCLIN-A2 RESIDUES 172-432 9606
97 1H1Q 2 B, D CYCLIN A2 9606
98 3DDP 2 B, D Cyclin-A2 UNP residues 169-430 9913
99 4EOS 2 B, D Cyclin-A2 C-terminal fragment 9606
100 2UZD 2 B, D CYCLIN A2 175-432 9606
101 4YC3 2 B G2/mitotic-specific cyclin-B1 N-terminal His tag removed by thrombin cleavage UNP residues 165-433 9606
102 2WHB 2 B, D CYCLIN-A2 RESIDUES 173-432 9606
103 2WMB 2 B, D CYCLIN-A2 RESIDUES 174-432 9606
104 2BKZ 2 B, D CYCLIN A2 RESIDUES 174-432 (C-TERMINAL PORTION) 9606
105 1H25 2 B, D CYCLIN A2 CYCLIN FOLD, RESIDUES 175-432 9606
106 3F5X 2 B, D Cyclin-A2 UNP residues 177-432 9606
107 1FVV 2 B, D CYCLIN A 9606
108 2WMA 2 B, D CYCLIN-A2 RESIDUES 174-432 9606
109 2C5X 2 B, D CYCLIN A2 9606
110 2C4G 2 B, D CYCLIN A2 RESIDUES 173-432 (C-TERMINAL PORTION) 9606
111 2JGZ 2 B G2/MITOTIC-SPECIFIC CYCLIN-B1 RESIDUES 167-426 9606
112 2WIP 2 B, D CYCLIN-A2 C-TERMINAL PORTION, RESIDUES 173-432 9606
113 1OL1 2 B, D CYCLIN A2 RESIDUES 173 - 432 9606
114 4CFM 2 B, D CYCLIN-A2 CDK-ACTIVATING FRAGMENT, RESIDUES 175-432 9606
115 1GY3 2 B, D CYCLIN A2 RESIDUES 175-432 9606
116 5NEV 2 B, D Cyclin-A2 9606
117 3EID 2 B, D Cyclin-A2 UNP residues 173-432 9606
118 1H28 2 B, D CYCLIN A2 CYCLIN FOLD, RESIDUES 175-432 9606
119 2CCI 2 B, D Cyclin-A2 RESIDUES 175-432 9606
120 3EOC 2 B, D Cyclin-A2 Proteolytic fragment: Residues 173-432 9606
121 2B9R 1 A, B Human cyclin B1 Residues 165-433 9606
122 3EJ1 2 B, D Cyclin-A2 UNP residues 113-432 9606
123 4CFX 2 B, D CYCLIN-A2 CDK-ACTIVATING FRAGMENT, RESIDUES 173-432 9606